ALDH1A1 and endometrial cancer: In our previous work, we observed clear enrichment of ALDH1/2, along with self-renewal and differentiation capacity, tumorigenic potential, expression of other stemness-associated markers, preference for oxidative metabolism, and resistance to chemotherapy in CSCs derived from the endometrial cancer cell line ECC-1 [19,20].